Gjin Ndrepepa

Showing 1-14 of 14 articles

Coronary interventions

Clinical and angiographic outcomes of crossing techniques for coronary chronic total occlusions: the ISAR-CTO registry

Xhepa E, Cassese S, Ndrepepa G, Joner M, Kufner S, Aytekin A, Lahmann A, Voll F, Fusaro M, Pinieck S, Schunkert H, Kastrati A, Fusaro M

October 1, 2021 | 10.4244/EIJ-D-20-01248

Coronary interventions

Clinical outcomes by optical characteristics of neointima and treatment modality in patients with coronary in-stent restenosis

Xhepa E, Bresha J, Joner M, Hapfelmeier A, Rivero F, Ndrepepa G, Nano N, Cuesta J, Kufner S, Cassese S, Bastante T, Aytekin A, Rroku A, García-Guimaraes M, Lahmann A, Pinieck S, Rai H, Fusaro M, Schunkert H, Pérez-Vizcayno M, Gonzalo N, Alfonso F, Kastrati A

August 6, 2021 | 10.4244/EIJ-D-20-00662

Obesity paradox after percutaneous coronary intervention - closing in on the truth behind the phenomenon

Ndrepepa G, Kastrati A

January 17, 2020 | 10.4244/EIJV15I13A208

Peripheral interventions

Paclitaxel density and clinical efficacy of drug-coated balloon angioplasty for femoropopliteal artery disease: meta-analysis and adjusted indirect comparison of 20 randomised trials

Cassese S, Ndrepepa G, Fusaro M, Kufner S, Xhepa E, Fusaro M

August 9, 2019 | 10.4244/EIJ-D-18-00550

No-reflow after percutaneous coronary intervention: a correlate of poor outcome in both persistent and transient forms

Ndrepepa G, Colleran R, Kastrati A

June 20, 2018 | 10.4244/EIJV14I2A21

Coronary interventions

Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: a meta-analysis of randomised trials

Cassese S, Ndrepepa G, Byrne R, Kufner S, Lahmann A, Mankerious N, Xhepa E, Laugwitz K, Schunkert H, Fusaro M, Kastrati A, Joner M

June 20, 2018 | 10.4244/EIJ-D-18-00024

Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials

Cassese S, Byrne R, Jüni P, Wykrzykowska J, Puricel S, Ndrepepa G, Schunkert H, Fusaro M, Cook S, Kimura T, Henriques J, Serruys P, Windecker S, Kastrati A

January 19, 2018 | 10.4244/EIJ-D-17-00492

Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials

Cassese S, Ndrepepa G, Byrne R, Kufner S, Xhepa E, De Waha A, Rheude T, Colleran R, Giacoppo D, Harada Y, Laugwitz K, Schunkert H, Fusaro M, Kastrati A

October 20, 2017 | 10.4244/EIJ-D-16-00871

Peripheral interventions

Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: a meta-analysis

Cassese S, Ndrepepa G, Kufner S, Byrne R, Giacoppo D, Ott I, Laugwitz K, Schunkert H, Kastrati A, Fusaro M

July 20, 2017 | 10.4244/EIJ-D-16-00735

Coronary interventions

Mechanical strategies to enhance myocardial salvage during primary percutaneous coronary intervention in patients with STEMI

Ndrepepa G, Kastrati A

June 20, 2016 | 10.4244/EIJV12I3A52

Coronary interventions

Impact of bivalirudin on post-procedural epicardial blood flow, risk of stent thrombosis and mortality after percutaneous coronary intervention

Fiedler A, Ndrepepa G, Schulz S, Floh S, Hoppmann P, Kufner S, Bernlochner I, Byrne R, Schunkert H, Laugwitz K, Kastrati A

February 12, 2016 | 10.4244/EIJV11I11A249

Proximal occlusion versus distal filter for cerebral protection during carotid stenting: updated meta-analysis of randomised and observational MRI studies

Cassese S, Ndrepepa G, King L, Nerad M, Schunkert H, Kastrati A, Ott I, Fusaro M

June 19, 2015 | 10.4244/EIJY15M03_01

Prognostic value of bleeding after percutaneous coronary intervention in patients with diabetes

Ndrepepa G, Schulz S, Neumann F, Laugwitz K, Richardt G, Byrne R, Pohler A, Kastrati A, Pache J

May 20, 2014 | 10.4244/EIJV10I1A14

Impact of perfusion restoration at epicardial and tissue levels on markers of myocardial necrosis and clinical outcome of patients with acute myocardial infarction

Ndrepepa G, Alger P, Fusaro M, Kufner S, Seyfarth M, Keta D, Mehilli J, Schömig A, Kastrati A

May 17, 2011 | 10.4244/EIJV7I1A21

1

Latest news

Three-year TAVI outcomes for BAV vs TAV

FREE ARTICLE - Dao Zhou et al.

January 20, 2022

Percutaneous management of left ventricular assist device outflow graft obstruction

FREE ARTICLE - Aleksandra Gasecka et al.

January 19, 2022

EuroCTO Club Consensus on Dual Lumen Microcatheters for CTO Recanalisation; Predicting Radial Crossover in ACS, the MATRIX score; DAPT duration for BRS; and more…

December 17, 2021

Lipid-rich plaque density and LDL-C in statin-treated vs statin-naïve patients

FREE ARTICLE - Rebecca Torguson et al.

January 17, 2022

Redo transcatheter mitral valve replacement in mitral annular calcification

FREE ARTICLE - Jennifer Jdaidani et al

January 13, 2022

TAVI vs SAVR in bicuspid aortic valve stenosis

FREE ARTICLE - Monil Majmundar et al.

January 12, 2022

Management of MR patients undergoing TMVI screening

FREE ARTICLE - Sebastian Ludwig et al.

January 7, 2022

Valvular disease